CTS Corp. (CTS) Misses Q2 EPS by 2c; Maintains Outlook
Tweet
Share
E-mailGet Alerts CTS Hot Sheet
Price: $62.57 -1.65%
Financial Fact:
Operating earnings: 12.49M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Financial Fact:
Operating earnings: 12.49M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
CTS Corp. (NYSE: CTS) reported Q2 EPS of $0.14, $0.02 worse than the analyst estimate of $0.16. Revenue for the quarter came in at $146.9 million versus the consensus estimate of $153 million.
Maintains outlook.
Maintains outlook.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- Eledon Pharmaceuticals, Inc. (ELDN) Misses Q2 EPS by 12c
- Eikon Therapeutics, Inc. (EIKN) Misses Q2 EPS by 163c
Create E-mail Alert Related Categories
Earnings, GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
